How well do you know your heart? Johnson & Johnson, in collaboration with Apple, is offering eligible U.S. adults 65 years and older the opportunity to join the Heartline™ Study virtually from home using their iPhone.

The Heartline™ Study is a nationwide heart health research study designed to explore if the Heartline Study app on iPhone and heart health features on Apple Watch can enable earlier detection of an irregular heart rhythm known as atrial fibrillation (AFib), and potentially improve heart health outcomes, including reducing the risk of stroke.

This study is virtual. This means you can participate from anywhere through your iPhone- including from the comfort of your home, without having to go to a doctor’s office. You’ll participate in a heart healthy engagement program with surveys, tips, and activities designed to help you become more engaged in your overall health. If you’re 65 or older and interested in being a part of the study, visit Heartline.com to learn more and download the app to see if you’re eligible to enroll.

How well do you know your heart? Johnson & Johnson, in collaboration with Apple, is offering eligible U.S. adults 65 years and older the opportunity to join the Heartline™ Study virtually from home using their iPhone.

The Heartline™ Study is a nationwide heart health research study designed to explore if the Heartline Study app on iPhone and heart health features on Apple Watch can enable earlier detection of an irregular heart rhythm known as atrial fibrillation (AFib), and potentially improve heart health outcomes, including reducing the risk of stroke.

This study is virtual. This means you can participate from anywhere through your iPhone- including from the comfort of your home, without having to go to a doctor’s office. You’ll participate in a heart healthy engagement program with surveys, tips, and activities designed to help you become more engaged in your overall health. If you’re 65 or older and interested in being a part of the study, visit Heartline.com to learn more and download the app to see if you’re eligible to enroll.

This program is designed to portray the experiences and perspectives of cardiovascular health care, law enforcement, and other professionals related to equality, justice, respect for human life, and health equity. This session will highlight potential efforts that individuals and organizations can do to combat racism and promote health and well-being.

View webinar on the scientific, clinical, therapeutic, and psychosocial facets of COVID-19 and racial/ethnicity.

ABC is pleased to announce the publication entitled “At the Heart of the Matter: Unmasking and Addressing COVID-19’s Toll on Diverse Populations,” authored by Norrisa Haynes, MD, MPH, ABC Board member, Lisa A. Cooper, MD, MPH, ABC Member and Michelle A. Albert, MD, MPH, ABC President, on behalf of the Association of Black Cardiologists.

View webinar on the epidemiology, clinical, prevention and social aspects of COVID-19 infection in diverse populations.

The coronavirus infection represents a global pandemic, that by definition, affects all populations. However, history has taught us that a differential impact often exists and is tightly linked to socio-demographic factors. There are a lot of questions about COVID-19, and the impact is evolving every day. Therefore, it is essential that we remain educated about ongoing events.

Stay informed with the latest science and clinical aspects of the coronavirus infection, and find helpful resources including frequently asked questions (FAQ) for health care providers, patients, and the public developed and curated by the ABC’s COVID-19 FAQ Watch editors and community programs committee.

The ABC Clinical Trials Network (ABC CTN), provides investigators from multiple specialities with unparalleled access to clinical studies of interest while offering industry “one-stop” access to multiple investigators that ascribe to the same standard of clinical trial conduct.

Comprised of investigators from a variety of therapeutic areas, the ABC CTN was developed to serve as a central “wheel hub” to identify and vet clinical trial opportunities, match investigators to trials of interest, and provide some of the infrastructure support that physicians say would be beneficial.